Abstract
Methotrexate is a folate antagonist that is used to treat acute leukemia, lymphoma, osteosarcoma, and leptomeningeal metastases. Methotrexate can be administered orally, intravenously, or intrathecally. Methotrexate given intravenously at high dose has been shown to decrease the incidence of hematologic, testicular, and central nervous system relapse.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Agarwal A, Vijay K, Thamburaj K, Ouyang T. Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke. Emerg Radiol. 2011;18(4):345–7.
Baehring JM, Fulbright RK. Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients. J Neurol Neurosurg Psychiatry. 2008;79:535–9.
Bay A, Oner AF, Etlik O, Yilmaz C, Caksen H. Myelopathy due to intrathecal chemotherapy: report of six cases. J Pediatr Hematol Oncol. 2005;27(5):270–2.
de Waal R, Algra PR, Heimans JJ, Wolbers JG, Scheltens P. Methotrexate induced brain necrosis and severe leukoencephalopathy due to disconnection of an Ommaya device. J Neurooncol. 1993;15(3):269–73.
Glass JO, Reddick WE, Li CS, Laningham FH, Helton KJ, Pui CH. Computer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate. Magn Reson Imaging. 2006;24(6):785–91.
Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol. 2008;19(1):178–84.
Küker W, Bader P, Herrlinger U, Heckl S, Nägele T. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI. J Neurooncol. 2005;73(1):47–9.
Reddick WE, Glass JO, Helton KJ, Langston JW, Xiong X, Wu S, Pui CH. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am J Neuroradiol. 2005;26(5):1263–9.
Reddick WE, Glass JO, Johnson DP, Laningham FH, Pui CH. Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemia. AJNR Am J Neuroradiol. 2009;30(10):1947–54.
Sandoval C, Kutscher M, Jayabose S, Tenner M. Neurotoxicity of intrathecal methotrexate: MR imaging findings. AJNR Am J Neuroradiol. 2003;24(9):1887–90.
Shanley DJ. Mineralizing microangiopathy: CT and MRI. Neuroradiology. 1995;37:331–3.
Visentin M, Zhao R, Goldman ID. The antifolates. Hematol Oncol Clin North Am. 2012;26(3):629–48, ix.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ginat, D.T. (2015). Methotrexate. In: Ginat, D., Small, J., Schaefer, P. (eds) Neuroimaging Pharmacopoeia. Springer, Cham. https://doi.org/10.1007/978-3-319-12715-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-12715-6_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12714-9
Online ISBN: 978-3-319-12715-6
eBook Packages: MedicineMedicine (R0)